NEXGEL, Inc. (NXGL)
NEXGEL, Inc. is a healthcare company specializing in the development and manufacturing of high water content hydrogels. Their products cater to diverse applications including wound care, medical diagnostics, transdermal drug delivery, and cosmetics.
Company Overview
NEXGEL, Inc. pioneers advanced hydrogel technology for diverse medical and cosmetic applications, offering innovative solutions in wound care, diagnostics, and drug delivery. With a focus on high water content and electron beam cross-linking, NEXGEL aims to capture significant market share through superior product performance and versatility.
Investment Thesis
Investing in NEXGEL, Inc. presents a compelling opportunity due to its innovative hydrogel technology and diverse application areas. The company's focus on high water content and electron beam cross-linking differentiates it within the market. While currently operating with a negative P/E ratio of -3.52 and a profit margin of -24.7%, NEXGEL's growth potential lies in expanding its market reach within wound care, diagnostics, transdermal drug delivery, and cosmetics. Key value drivers include securing strategic partnerships, expanding production capacity, and obtaining regulatory approvals for new products. Upcoming catalysts include potential collaborations with major players in the healthcare and cosmetic industries, which could significantly boost revenue and profitability. The company's small market capitalization of $0.01 billion suggests substantial upside potential if it can successfully execute its growth strategy.
Key Highlights
- Market capitalization of $0.01 billion indicates potential for high growth.
- Gross margin of 38.3% demonstrates the ability to generate profit from sales.
- Beta of 0.59 suggests lower volatility compared to the overall market.
- Negative P/E ratio of -3.52 reflects current unprofitability but also potential for future earnings growth.
- Focus on high water content hydrogels positions NEXGEL in a niche market with growing demand.
Competitors
Strengths
- Proprietary hydrogel technology.
- Diverse application areas (wound care, diagnostics, drug delivery, cosmetics).
- Experienced management team.
- Focus on high-growth markets.
Weaknesses
- Small market capitalization.
- Limited financial resources.
- Negative profitability.
- Dependence on key customers and partners.
Catalysts
- Upcoming: Potential FDA approvals for new hydrogel-based medical devices.
- Ongoing: Strategic partnerships with pharmaceutical companies for transdermal drug delivery applications.
- Ongoing: Expansion of manufacturing capacity to meet increasing demand.
- Upcoming: Positive clinical trial results for hydrogel-based wound care products.
- Ongoing: Increased adoption of hydrogel technology in cosmetic applications.
Risks
- Potential: Competition from larger companies with greater resources.
- Potential: Regulatory delays or unfavorable outcomes.
- Ongoing: Dependence on key suppliers for raw materials.
- Potential: Product liability claims.
- Ongoing: Economic downturn affecting demand for discretionary healthcare and cosmetic products.
Growth Opportunities
- Expansion into Advanced Wound Care: The global advanced wound care market is projected to reach $22 billion by 2027. NEXGEL can capitalize on this by developing and marketing innovative hydrogel dressings for chronic wounds, burns, and surgical incisions. This includes leveraging their high water content hydrogels to promote faster healing and reduce infection rates. Success in this area would require strategic partnerships with hospitals and wound care centers, as well as regulatory approvals for new products.
- Penetration of the Transdermal Drug Delivery Market: The transdermal drug delivery market is expected to reach $80 billion by 2028. NEXGEL can leverage its hydrogel technology to develop novel transdermal patches for various therapeutic areas, including pain management, hormone replacement therapy, and cardiovascular diseases. This involves optimizing the hydrogel formulation for enhanced drug permeation and patient compliance. Strategic alliances with pharmaceutical companies will be crucial for successful market entry.
- Growth in Medical Diagnostics Applications: The medical diagnostics market is experiencing rapid growth, driven by advancements in point-of-care testing and personalized medicine. NEXGEL can expand its presence in this market by developing hydrogel-based biosensors and diagnostic kits for various diseases and conditions. This requires collaboration with diagnostic companies and research institutions to develop and validate new diagnostic assays. The timeline for commercialization will depend on regulatory approvals and market acceptance.
- Expansion in Cosmetic Applications: The global cosmetics market is a multi-billion dollar industry, with a growing demand for innovative and effective skincare products. NEXGEL can leverage its hydrogel technology to develop advanced cosmetic products, such as moisturizing masks, anti-aging creams, and sunscreens. This involves formulating hydrogels with active ingredients and optimizing them for skin hydration and delivery. Strategic partnerships with cosmetic companies and retailers will be essential for market penetration.
- Strategic Partnerships and Collaborations: Forming strategic alliances with established players in the healthcare, pharmaceutical, and cosmetic industries can provide NEXGEL with access to new markets, technologies, and resources. These partnerships can involve joint product development, licensing agreements, and distribution arrangements. The timeline for realizing the benefits of these partnerships will depend on the specific terms and objectives of each collaboration. Ongoing: NEXGEL can actively pursue these partnerships to accelerate its growth and expand its market reach.
Opportunities
- Expansion into new geographic markets.
- Development of new hydrogel-based products.
- Strategic partnerships with major healthcare and cosmetic companies.
- Increasing demand for advanced wound care and drug delivery solutions.
Threats
- Competition from larger and more established companies.
- Regulatory hurdles and approval processes.
- Technological advancements that could render existing products obsolete.
- Economic downturns that could reduce demand for medical and cosmetic products.
Competitive Advantages
- Proprietary hydrogel formulations and manufacturing processes.
- Expertise in high water content and electron beam cross-linking technologies.
- Established relationships with key customers in the medical and cosmetic industries.
- Focus on specialized applications with high growth potential.
About
NEXGEL, Inc., headquartered in Langhorne, Pennsylvania, is a manufacturer of high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Founded in 1997, the company initially operated as AquaMed Technologies, Inc. before rebranding to NEXGEL, Inc. in November 2019. NEXGEL's core business revolves around the production of advanced hydrogels utilized in a variety of applications across the medical and cosmetic sectors. These applications include wound care, where the hydrogels provide a moist environment conducive to healing; medical diagnostics, where they serve as a medium for various tests; transdermal drug delivery, enabling controlled release of medication through the skin; and cosmetics, where they enhance product efficacy and user experience. With a focus on innovation and quality, NEXGEL strives to meet the evolving needs of its customers and capitalize on the growing demand for advanced hydrogel solutions. The company's strategic location and experienced team position it well to serve both domestic and international markets, fostering long-term growth and value creation.
What They Do
- Manufactures high water content hydrogels.
- Utilizes electron beam cross-linking technology.
- Produces aqueous polymer hydrogels and gels.
- Develops products for wound care applications.
- Supplies hydrogels for medical diagnostics.
- Creates hydrogels for transdermal drug delivery.
- Offers hydrogels for cosmetic applications.
Business Model
- Manufacturing and selling hydrogel products.
- Generating revenue through direct sales to medical and cosmetic companies.
- Developing and licensing hydrogel technologies.
- Collaborating with partners for product development and distribution.
Industry Context
NEXGEL operates within the medical instruments and supplies industry, a sector characterized by continuous innovation and increasing demand for advanced materials. The global hydrogel market is experiencing steady growth, driven by applications in wound care, drug delivery, and regenerative medicine. Key trends include the development of biocompatible and biodegradable hydrogels, as well as the integration of hydrogels with advanced technologies such as 3D printing. Competitors in this space include companies like ENLV (Enlivex Therapeutics Ltd.), FEMY (Femasys Inc.), GDTC (Guardion Health Sciences, Inc.), HBIO (Harvard Bioscience, Inc.), and IINN (Inno Holdings Inc.), each with their own specific focus areas and market strategies. NEXGEL aims to differentiate itself through its expertise in high water content hydrogels and its diverse application portfolio.
Key Customers
- Wound care product manufacturers.
- Medical diagnostic companies.
- Pharmaceutical companies involved in transdermal drug delivery.
- Cosmetic companies producing skincare products.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | $3M | $-665,000 | $0.00 |
| Q1 2025 | $3M | $-712,000 | $0.00 |
| Q4 2024 | $3M | $-850,000 | $0.00 |
| Q3 2024 | $3M | $-693,000 | $0.00 |
Source: Company filings
Chart & Info
Price Chart
NEXGEL, Inc. (NXGL) stock price: $1.77 (-0.04, -2.21%)
Latest News
-
Earnings Scheduled For November 11, 2025
benzinga · Nov 11, 2025
-
Earnings Scheduled For August 12, 2025
benzinga · Aug 12, 2025
-
Earnings Scheduled For May 13, 2025
benzinga · May 13, 2025
-
52 Weeks High And Low Article
benzinga · Feb 11, 2022
Technical Analysis
Rationale
AI-generated technical analysis for NXGL including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss NEXGEL, Inc. (NXGL) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for NXGL.
Make a Prediction
Set your price target for NEXGEL, Inc. (NXGL), choose a timeframe, and track your prediction accuracy.
Current price: $1.77
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NXGL.
Price Targets
Wall Street price target analysis for NXGL.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 10/100
Revenue surged 112.5% year-over-year, indicating explosive demand and rapid market share expansion.
-
Gross Margin 8/100
Gross margin at 40.8% indicates good unit economics and healthy profitability per sale.
-
Operating Leverage 6/100
Revenue growth is driving operating leverage, meaning profits can grow faster than costs.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates NXGL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Frequently Asked Questions
What does NEXGEL, Inc. do?
NEXGEL, Inc. is a manufacturer of high water content hydrogels, utilizing electron beam cross-linking and aqueous polymer technology. These hydrogels are used in a variety of applications, including wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company's business model centers around developing and manufacturing these specialized hydrogels and selling them to companies that incorporate them into their final products. NEXGEL aims to be a leading provider of advanced hydrogel solutions, capitalizing on the growing demand for innovative materials in the healthcare and cosmetic industries. Their focus on high-quality, customizable hydrogels positions them as a valuable partner for companies seeking to enhance their product offerings.
Is NXGL stock a good buy?
NXGL stock presents a high-risk, high-reward investment opportunity. While the company currently operates with negative profitability, its innovative hydrogel technology and diverse application areas offer significant growth potential. A key consideration is the company's small market capitalization of $0.01 billion, which suggests substantial upside if NEXGEL can successfully execute its growth strategy. Investors should carefully evaluate the company's financial performance, competitive landscape, and regulatory risks before making an investment decision. The gross margin of 38.3% indicates potential for profitability as the company scales its operations and secures strategic partnerships. However, the negative P/E ratio reflects the current lack of earnings, requiring investors to focus on future growth prospects.
What are the main risks for NXGL?
NEXGEL faces several key risks, including competition from larger and more established companies in the medical and cosmetic industries. The company's small size and limited financial resources make it vulnerable to competitive pressures. Regulatory hurdles and approval processes also pose a significant risk, as delays or unfavorable outcomes could impact the commercialization of new products. Additionally, NEXGEL is dependent on key suppliers for raw materials, which could disrupt its supply chain if these relationships are compromised. Product liability claims represent another potential risk, particularly in the medical device and pharmaceutical sectors. Finally, economic downturns could reduce demand for discretionary healthcare and cosmetic products, impacting NEXGEL's revenue and profitability.
Is NXGL a good stock to buy?
Whether NXGL is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.
What is the NXGL MoonshotScore?
The MoonshotScore for NXGL is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.
How often is NXGL data updated?
NXGL stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to NXGL is aggregated continuously from premium financial news sources throughout the day.
What are the growth catalysts for NXGL?
Growth catalysts for NEXGEL, Inc. (NXGL) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes NEXGEL, Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.
Who are NXGL's main competitors?
NEXGEL, Inc. (NXGL) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether NXGL has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.
What do analysts say about NXGL?
Wall Street analyst coverage for NXGL includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.
What is NXGL's market cap?
Market capitalization (market cap) for NXGL is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows NXGL's current market cap alongside enterprise value and other valuation metrics.
How has NXGL stock performed recently?
NXGL's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing NXGL's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.
What are the risks of investing in NXGL?
Key risk categories for NXGL include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures NXGL's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.
Are insiders buying or selling NXGL?
Insider trading activity for NXGL tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.
Is NXGL a good stock for beginners?
NEXGEL, Inc. (NXGL) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is NXGL for first-time investors?
Every stock carries risk, including NEXGEL, Inc. (NXGL). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like NXGL.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- Future growth projections are based on management's expectations and are subject to change.
- Investment in micro-cap stocks carries significant risk.